4.6 Review

Binding of Natural Inhibitors to Respiratory Complex I

期刊

PHARMACEUTICALS
卷 15, 期 9, 页码 -

出版社

MDPI
DOI: 10.3390/ph15091088

关键词

mitochondria; respiratory chain; NADH dehydrogenase; Parkinson's disease; rotenone; piericidin; acetogenin

资金

  1. Deutsche Forschungsgemeinschaft [CRC1507 P14]

向作者/读者索取更多资源

This article summarizes the structure and redox mechanism of respiratory complex I, as well as the binding modes and inhibitory mechanisms of inhibitors in the Q reduction site and Q access pathway. It provides important insights into the crucial protein complex involved in mitochondrial oxidative phosphorylation.
NADH:ubiquinone oxidoreductase (respiratory complex I) is a redox-driven proton pump with a central role in mitochondrial oxidative phosphorylation. The ubiquinone reduction site of complex I is located in the matrix arm of this large protein complex and connected to the membrane via a tunnel. A variety of chemically diverse compounds are known to inhibit ubiquinone reduction by complex I. Rotenone, piericidin A, and annonaceous acetogenins are representatives of complex I inhibitors from biological sources. The structure of complex I is determined at high resolution, and inhibitor binding sites are described in detail. In this review, we summarize the state of knowledge of how natural inhibitors bind in the Q reduction site and the Q access pathway and how their inhibitory mechanisms compare with that of a synthetic anti-cancer agent.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据